FDA Approved: NIVESTYM — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)

View source ↗

Summary

The FDA approved a supplemental application for NIVESTYM (filgrastim-aafi) from Pfizer Laboratories Div Pfizer Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Marrow Transplantation
• Chemotherapy-induced Neutropenia
• Neutropenia

Drugs mentioned

• NIVESTYM (FILGRASTIM-AAFI)

Snippet

SUPPL AP for NIVESTYM (FILGRASTIM-AAFI)